肝硬化门静脉高压外科治疗的现状及进展

张春雨; 刘作金

doi:10.3969/j.issn.1001-5256.2020.02.040

肝硬化门静脉高压外科治疗的现状及进展

DOI: 10.3969/j.issn.1001-5256.2020.02.040

重庆医科大学附属第二医院肝胆外科

基金项目:

国家自然科学基金(81470899)；

详细信息

中图分类号: R657.34
计量
- 文章访问数: 1205
- HTML全文浏览量: 63
- PDF下载量: 307
- 被引次数: 0
出版历程
- 收稿日期: 2019-10-01
- 出版日期: 2020-02-20

Surgical treatment of cirrhotic portal hypertension: Current status and research advances

Department of Hepatobiliary Surgery,The Second Affiliated Hospital of Chongqing Medical University

Research funding:

摘要

摘要:
肝硬化可以导致门静脉压力病理性持续升高,出现食管胃底静脉曲张、腹水、肝性脑病以及继发循环功能障碍等多种并发症。门静脉高压症以综合治疗为主,其中外科治疗主要是控制并预防食管胃底静脉曲张破裂大出血。介入治疗和肝移植已逐渐成为手术干预的一种常规手段,能够显著提高患者生活质量,但断流术和分流术仍是目前的主流术式。肝硬化门静脉高压的每一种手术策略都有其自身的特点,综合评估患者一般情况及病情特点,采用个性化治疗方案以达到最佳疗效将是未来的趋势。
- 肝硬化 /
- 高血压,门静脉 /
- 外科手术
Abstract:
Liver cirrhosis can lead to continuous pathological elevation of portal venous pressure,resulting in various complications such as esophageal and gastric varices,ascites,hepatic encephalopathy,and secondary circulatory dysfunction. Multimodality therapy is the main treatment method for portal hypertension,among which surgical treatment is mainly used to control and prevent massive esophagogastric variceal bleeding. Currently,interventional therapy and liver transplantation have gradually become a routine method for surgical intervention and can significantly improve patients' quality of life,but devascularization and shunt are still the mainstream surgical procedures. Each surgical strategy for cirrhotic portal hypertension has its own characteristics. It will be a trend in the future to evaluate patients' general conditions and clinical features and select individualized treatment regimens to achieve the best treatment outcome.
- liver cirrhosis /
- hypertension,portal /
- surgical procedures,operative

HTML全文

参考文献(30)

[1] GARCÍA-PAGÁN JC,GRACIA-SANCHO J,BOSCH J.Functional aspects on the pathophysiology of portal hypertension in cirrhosis[J]. J Hepatol,2012,57(2):458-461.

[2] Chinese Portal Hypertension Diagnosis and Monitoring Study Group(CHESS); Minimally Invasive Intervention Collaborative Group,Chinese Society of Gastroenterology; Emergency Intervention Committee,Chinese College of Interventionalists,et al. Consensus on clinical application of hepatic venous pressure gradient in China(2018)[J]. J Clin Hepatol,2018,34(12):2526-2536.(in Chinese)中国门静脉高压诊断与监测研究组，中华医学会消化病学分会微创介入协作组，中国医师协会介入医师分会急诊介入专业委员会，等．中国肝静脉压力梯度临床应用专家共识(2018版)[J]．临床肝胆病杂志，2018,34(12):2526-2536.

[3] YANG LY. Attention to the surgical treatment of portal hypertension in China[J]. Chin J Dig Surg,2018,17(10):971-975.(in Chinese)杨连粤．重视我国门静脉高压症外科治疗的问题[J]．中华消化外科杂志，2018,17(10):971-975.

[4] WANG Q,DING X. A comparative study of the efficacy of the modified sugiura procedure and the Hassab procedure for treatment of rebleeding after endoscopic variceal ligation due to portal hypertension[J]. Am Surg,2016,82(6):557-564.

[5] ZHANG YF,WEI AL,HUANG J,et al. Effect of modified Sugiura’s operation on portal hemodynamics in cirrhotic patients with portal hypertension[J]. J Prac Hepatol,2019,22(4):553-556.(in Chinese)张云峰，魏瑷琳，黄进，等．采用改良的Sugiura术治疗肝硬化并发门脉高压症患者疗效研究[J]．实用肝脏病杂志，2019,22(4):553-556.

[6] DENG YT. Clinical effect of selective devascularization and combined devascularization on portal hypertension[J]. Clin Res Pract,2017,2(28):65-66.(in Chinese)邓银田．选择性断流术和联合断流术治疗门脉高压症的临床效果比较[J]．临床医学研究与实践，2017,2(28):65-66.

[7] ZHAO Y,WANG C. The therapeutic effect of splenectomy plus selective pericardial devascularization versus conventional pericardial devascularization on portal hypertension in China:A meta-analysis[J]. Oncotarget,2018,9(20):15398-15408.

[8] LIN J,LIU Q,LIANG Z,et al. Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension[J]. Wideochir Inne Tech Maloinwazyjne,2019,14(2):187-194.

[9] FISICHELLA PM,WONG YM,PAPPAS SG,et al. Laparoscopic splenectomy:Perioperative management, surgical technique,and results[J]. J Gastrointest Surg,2014,18(2):404-410.

[10] TAJIRI T,ONDA M,YOSHIDA H,et al. Long-term results of modified distal splenorenal shunts for the treatment of esophageal varices[J]. Hepatogastroenterology,2000,47(33):720-723.

[11] QU K,LIU C. Coronary-caval shunt for upper gastrointestinal bleeding caused by portal hypertension:Analysis of domestic case report over 40 years[J/CD]. Chin J Hepat Surg(Electronic Edition),2017,6(2):113-117.(in Chinese)曲凯，刘昌．冠腔分流术治疗门静脉高压症上消化道出血———40年国内报道病例分析[J/CD]．中华肝脏外科手术学电子杂志，2017,6(2):113-117.

[12] ZHANG JS,CHENG W,LI L. Laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension in children with congenital hepatic fibrosis:A case report[J]. Medicine(Baltimore),2017,96(3):e5843.

[13] YIN L,LIU H,ZHANG Y,et al. The surgical treatment for portal hypertension:A systematic review and meta-analysis[J].ISRN Gastroenterol,2013,2013:464053.

[14] DU L,WU W,ZHANG Y,et al. Effects of modified splenocaval shunt plus devascularization on esophagogastric variceal bleeding:A comparative study of this treatment and devascularization only in cirrhotic portal hypertension[J]. J Hepatobiliary Pancreat Sci,2010,17(5):657-665.

[15] WANG YP,YAN JZ,ZHANG SJ,et al. The efficacy and safety of shunt combined with devascularization for portal hypertension:A systematic review and meta-analysis[J]. J Nongken Medicine,2018,40(1):1-8.(in Chinese)汪运鹏，鄢金柱，张示杰，等．分流术联合断流术治疗门静脉高压症有效性及安全性的系统评价[J]．农垦医学，2018,40(1):1-8.

[16] GEEROMS B,LALEMAN W,LAENEN A,et al. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients:Longterm patency and clinical outcome results[J]. Eur Radiol,2017,27(5):1795-1803.

[17] DING ZF,YIN SW,ZHANG GB,et al. Clinical effect of Viatorr stent versus double-stent technique in transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol,2018,34(3):579-582.(in Chinese)丁智锋，殷世武，张国兵，等．Viatorr支架与双支架技术行经颈静脉肝内门体分流术的临床疗效观察[J]．临床肝胆病杂志，2018,34(3):579-582.

[18] ZHANG K,SUN X,WANG G,et al. Treatment outcomes of percutaneous transhepatic variceal embolization versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding[J]. Medicine(Baltimore),2019,98(18):e15464.

[19] HUO F,CHEN JX,ZHENG YJ,et al. Effects,status and problems of liver transplantation in the treatment of portal hypertension[J]. Chin J Dig Surg,2018,17(10):976-980.(in Chinese)霍枫，陈建雄，郑于剑，等．肝移植治疗门静脉高压症的作用与地位及需要注意的问题[J]．中华消化外科杂志，2018,17(10):976-980.

[20] SHEN ZY,GU C,ZHENG H,et al. A twenty-year review of clinical liver transplantation[J]. Chin Crit Care Med,2019,31(3):269-280.(in Chinese)沈中阳，谷川，郑虹，等．临床肝脏移植20年回顾[J]．中华危重病急救医学，2019,31(3):269-280.

[21] SCHMITZ V,SCHOENING W,JELKMANN I,et al. Different cava reconstruction techniques in liver transplantation:Piggyback versus cava resection[J]. Hepatobiliary Pancreat Dis Int,2014,13(3):242-249.

[22] RELA M,KALIAMOORTHY I,REDDY MS. Current status of auxiliary partial orthotopic liver transplantation for acute liver failure[J]. Liver Transpl,2016,22(9):1265-1274.

[23] ZHU ZJ. Indication,operation and prospect of auxiliary liver transplantation[J]. Chin J Bases Clin Gen Surg,2018,25(8):905-908.(in Chinese)朱志军．辅助性肝移植的适应证、术式及前景[J]．中国普外基础与临床杂志，2018,25(8):905-908.

[24] FERRARESE A,ZANETTO A,GAMBATO M,et al. Liver transplantation for viral hepatitis in 2015[J]. World J Gastroenterol,2016,22(4):1570-1581.

[25] AL-HAMOUDI W,ELSIESY H,BENDAHMASH A,et al. Liver transplantation for hepatitis B virus:Decreasing indication and changing trends[J]. World J Gastroenterol,2015,21(26):8140-8147.

[26] HE R,ZHANG K,LI BL,et al. Investigation of the operation time after failure of endoscopic therapy of patients with esophagogastric variceal bleeding caused by portal hypertension liver cirrhosis[J/CD]. Chin J Liver Dis(Electr Version),2014,6(3):17-20.(in Chinese)赫嵘，张珂，李宝亮，等．肝硬化门脉高压食管胃底静脉曲张破裂出血内窥镜治疗失败后再手术时机探讨[J/CD]．中国肝脏病杂志(电子版)，2014,6(3):17-20.

[27] OH SH,KIM SJ,RHEE KW,et al. Endoscopic cyanoacrylate injection for the treatment of gastric varices in children[J].World J Gastroenterol,2015,21(9):2719-2724.

[28] ORLOFF MJ,HYE RJ,WHEELER HO,et al. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis[J].Surgery,2015,157(6):1028-1045.

[29] GARCIA-TSAO G,ABRALDES JG,BERZIGOTTI A,et al.Portal hypertensive bleeding in cirrhosis:Risk stratification,diagnosis,and management:2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology,2017,65(1):310-335.

[30] WANG YJ,LUO DY,LI H,et al. Comparison of effects on immune function of patients with portal hypertension and hypersplenism between total splenectomy and partial splenectomy[J/CD]. Chin J Hepat Surg(Electronic Edition),2017,6(3):216-221.(in Chinese)王永军，罗大勇，李恒，等．全脾切除术与部分脾切除术对门静脉高压症脾功能亢进患者免疫功能影响的比较[J/CD]．中华肝脏外科手术学电子杂志，2017,6(3):216-221.

施引文献

资源附件(0)

访问统计